JBS N.V.: Capital Research holds 5.4% stake (43,903,609)
Capital Research Global Investors filed a Schedule 13G reporting beneficial ownership of 5.4% of JBS N.V. common stock, equal to 43,903,609 shares, with the event date 09/30/2025.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Capital Research Global Investors filed a Schedule 13G reporting beneficial ownership of 5.4% of JBS N.V. common stock, equal to 43,903,609 shares, with the event date 09/30/2025.
The filer reports sole voting power over 43,758,295 shares and sole dispositive power over 43,903,609 shares. The filing notes that the stake includes 43,758,257 Depositary Receipts, each representing one common share, and references 814,216,001 shares believed outstanding. The securities are stated to be held in the ordinary course of business and not for the purpose of changing or influencing control.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Capital Research disclose about JBS (JBS)?
What is the date of the ownership event for JBS (JBS)?
Does the filing state an intent to influence control of JBS?
What portion of the reported stake is in Depositary Receipts?
What type of filer is Capital Research in this Schedule 13G?
AI-generated analysis. How Rhea-AI works. Not financial advice.